Associated Papers
Management of hereditary angioedema with normal C1Inh: a series of 163 French patients.
Bocquet A et al.
Orphanet Journal of Rare Diseases, 2025
C1 inhibitor: from complement system to bradykinin angioedema.
Defendi F et al.
Current Opinion in Immunology, 2025
Insights From the First 820 Patients From the Brazilian Multicenter Registry of Hereditary Angioedema: The Key Role of Genetic Testing and Targeted Therapies.
Ferriani MPL et al.
The Journal of Allergy and Clinical Immunology. in Practice, 2025
Hypertension risk in patients having hereditary angioedema with plasminogen gene mutation K330E.
Bork K et al.
The Journal of Allergy and Clinical Immunology. in Practice, 2025
[A CASE OF HEREDITARY ANGIOEDEMA WITH NORMAL C1 INHIBITOR (HEREDITARY ANGIOEDEMA TYPE III) WITH A PATHOGENIC VARIANT IN THE PLG GENE].
Sugimoto H et al.
Arerugi = [allergy], 2025
A clinical evaluation of patients with known mutations (plasminogen and factor XII) with a focus on prophylactic treatment.
Lochbaum R et al.
The Journal of Dermatological Treatment, 2024
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation.
Petersen RS et al.
Seminars in Thrombosis and Hemostasis, 2024
Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency.
Vincent D et al.
The Journal of Allergy and Clinical Immunology. Global, 2024
Plasminogen missense variants and their involvement in cardiovascular and inflammatory disease.
Brito-Robinson T et al.
Frontiers in Cardiovascular Medicine, 2024
Gene Mutations Linked to Hereditary Angioedema in Solitary Angioedema Patients With Normal C1 Inhibitor.
Bork K et al.
The Journal of Allergy and Clinical Immunology. in Practice, 2023
Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers.
Lyons JJ et al.
The Journal of Allergy and Clinical Immunology. in Practice, 2023
A Missense Mutation of the Plasminogen Gene in a Japanese Family with Hereditary Angioedema with Normal C1 Inhibitor: Third Family Survey in Asia.
Yakushiji H et al.
Internal Medicine (tokyo, Japan), 2023
Hereditary angio-oedema with normal C1-INH, developing recurrent acute abdomen after taking low-dose oestrogen-progestin: A case report.
Nakayama T et al.
Modern Rheumatology Case Reports, 2023
Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor.
Jones D et al.
Journal of Asthma and Allergy, 2023
Hereditary angioedema in children and adolescents.
Mansour E et al.
Allergologia Et Immunopathologia, 2022
SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE.
Drouet C et al.
Frontiers in Allergy, 2022
Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin.
Hintze S et al.
Frontiers in Physiology, 2022
Clinical and genetic features of hereditary angioedema with and without C1-inhibitor (C1-INH) deficiency in Japan.
Hashimura C et al.
Allergy, 2021
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine.
Zhou Y et al.
Science Advances, 2021
Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 Gene.
Sharma J et al.
Clinical Reviews in Allergy & Immunology, 2021
Leveraging Genetics for Hereditary Angioedema: A Road Map to Precision Medicine.
Germenis AE et al.
Clinical Reviews in Allergy & Immunology, 2021
The Genetics of Hereditary Angioedema: A Review.
Santacroce R et al.
Journal of Clinical Medicine, 2021
Screening for Plasminogen Mutations in Hereditary Angioedema Patients.
Farkas H et al.
Genes, 2021
Pathophysiology and underlying mechanisms in hereditary angioedema.
López Lera A
Balkan Medical Journal, 2021
Angioedema without wheals: a clinical update.
Gülbahar O
Balkan Medical Journal, 2021
[Diagnosis and treatment of hereditary angioedema with normal C1-inhibitor level].
Emelyanov AV et al.
Terapevticheskii Arkhiv, 2020
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor.
Loules G et al.
Journal of Clinical Medicine, 2020
Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
Bork K et al.
Orphanet Journal of Rare Diseases, 2020
Plasminogen glycoforms alteration and activation susceptibility associated with the missense variant p.Lys330Glu in HAE-PLG patients.
Parsopoulou F et al.
Allergy, 2020
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor.
Bova M et al.
Allergy, 2020
Angioedema without urticaria: novel findings which must be measured in clinical setting.
Veronez CL et al.
Current Opinion in Allergy and Clinical Immunology, 2020
Study of angiopoietin and plasminogen genes in hereditary angioedema.
Kruk T et al.
Revista Da Associacao Medica Brasileira (1992), 2020
Hereditary angioedema in a single family with specific mutations in both plasminogen and SERPING1 genes.
Bork K et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : Jddg, 2020
Bork K et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : Jddg, 2020
An update on the genetics and pathogenesis of hereditary angioedema.
Banday AZ et al.
Genes & Diseases, 2020
Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants.
Marceau F et al.
Frontiers in Medicine, 2020
Hereditary angioedema: Looking for bradykinin production and triggers of vascular permeability.
Margaglione M et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology, 2019
Hereditary Angioedema: Insights into inflammation and allergy.
Maas C et al.
Molecular Immunology, 2019
Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema.
Recke A et al.
Clinical and Translational Allergy, 2019
Genotype-first analysis of a generally healthy population cohort supports genetic testing for diagnosis of hereditary angioedema of unknown cause.
Bodian DL et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, 2019
Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics.
Marcelino-Rodriguez I et al.
Frontiers in Genetics, 2019
Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: Three additional French families.
Belbézier A et al.
Allergy, 2018
On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema.
Germenis AE et al.
Allergy, 2018
A missense mutation in the plasminogen gene, within the plasminogen kringle 3 domain, in hereditary angioedema with normal C1 inhibitor.
Dewald G
Biochemical and Biophysical Research Communications, 2018
Hereditary angioedema with a mutation in the plasminogen gene.
Bork K et al.
Allergy, 2018
[Biochemical diagnosis of hereditary hyperlipoproteinemias].
Tvorogova MG et al.
Terapevticheskii Arkhiv, 1998
[Difficulties in the diagnosis of hereditary familial amyloidosis].
Anokhin IM et al.
Terapevticheskii Arkhiv, 1995
[A case of hereditary angioneurotic edema provoked by functional insufficiency of C1-inactivator].
Didkovskiĭ NA et al.
Terapevticheskii Arkhiv, 1989